News
BVS
9.83
+1.65%
0.16
Bioventus to report fiscal Q1 results, host conference call
PUBT · 1d ago
Weekly Report: what happened at BVS last week (0420-0424)?
Weekly Report · 3d ago
Bioventus announces annual shareholder meeting
PUBT · 04/22 11:52
Weekly Report: what happened at BVS last week (0413-0417)?
Weekly Report · 04/20 10:27
Strength Seen in Bioventus (BVS): Can Its 6.6% Jump Turn into More Strength?
NASDAQ · 04/16 12:00
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 04/14 21:05
Weekly Report: what happened at BVS last week (0406-0410)?
Weekly Report · 04/13 10:31
Weekly Report: what happened at BVS last week (0330-0403)?
Weekly Report · 04/06 10:32
Weekly Report: what happened at BVS last week (0323-0327)?
Weekly Report · 03/30 10:32
Bioventus initiated with an Outperform at CJS Securities
TipRanks · 03/27 13:00
Weekly Report: what happened at BVS last week (0316-0320)?
Weekly Report · 03/23 10:28
Weekly Report: what happened at BVS last week (0309-0313)?
Weekly Report · 03/16 10:27
Bioventus Director’s Surprise Stock Move Shakes Up Investor Buzz
TipRanks · 03/14 02:04
Bioventus Director Michelle McMurry-Heath Disposes of Common Shares
Reuters · 03/13 21:27
Bioventus Earnings Call Signals Profitable Growth Ahead
TipRanks · 03/10 00:11
Bioventus management to meet with Barrington
TipRanks · 03/09 18:55
Weekly Report: what happened at BVS last week (0302-0306)?
Weekly Report · 03/09 10:28
Bioventus Is Maintained at Outperform by Barrington Research
Dow Jones · 03/06 18:56
Bioventus Price Target Raised to $14.00/Share From $13.00 by Barrington Research
Dow Jones · 03/06 18:56
Barrington Research Maintains Outperform on Bioventus, Raises Price Target to $14
Benzinga · 03/06 18:47
More
Webull provides a variety of real-time BVS stock news. You can receive the latest news about Bioventus Inc. through multiple platforms. This information may help you make smarter investment decisions.
About BVS
Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.